ERNEST MARIO
CIK 1180469 · last filed 2024-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.70M
Companies
15
Total Filings
301
Lifetime Open-Market Net
-$44.39M
Filer Profile
Reported Address
20 FAIRMOUNT AVENUEP.O. BOX 445
CHATHAM, NJ 07928
Related Filers
CELGENE CORP /DE/ — 64 joint filings, latest 2019-11-22
PHARMACEUTICAL PRODUCT DEVELOPMENT INC — 55 joint filings, latest 2011-12-06
BOSTON SCIENTIFIC CORP — 36 joint filings, latest 2015-11-17
MAXYGEN INC — 12 joint filings, latest 2012-06-07
MILLENNIUM PHARMACEUTICALS INC — 1 joint filings, latest 2002-10-18
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.
View filings on SEC EDGAR.
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SOLENO THERAPEUTICS INC (SLNO) Delisted | Director | 214,855 | $53.01 | $11.39M | $0 | 20 | 2024-06-10 |
| HYPERION DEFI, INC. (EYEN) Delisted | Director | 4,784 | $15.82 | $75.7K | $1.19M | 8 | 2021-11-22 |
| Kindred Biosciences, Inc. (KIN) Delisted | Director | 125,000 | $9.25 | $1.16M | $387.0K | 14 | 2021-01-22 |
| CELGENE CORP /DE/ (CELGZ) Delisted | Director | 0 | — | — | -$26.01M | 51 | 2019-11-22 |
| SOLENO THERAPEUTICS INC (SLNOW) Delisted | Director | 471,218 | — | — | $0 | 12 | 2019-06-12 |
| TNXP | Director | 0 | $11.87 | $0 | $1.03M | 30 | 2018-06-27 |
| CHIMERIX INC (CMRX) Delisted | Director | 121,072 | $8.54 | $1.03M | $1.22M | 36 | 2018-05-21 |
| SOLENO THERAPEUTICS INC (CAPNW) Delisted | Director | 1,795,929 | — | — | $0 | 2 | 2017-05-09 |
| SOLENO THERAPEUTICS INC (CAPN.W) Delisted | Director | 1,789,678 | — | — | $522.7K | 20 | 2016-10-11 |
| BSX | Director | 86,032 | $42.98 | $3.70M | -$4.09M | 47 | 2015-11-17 |
| XENOPORT INC (XNPT) Delisted | Director | 88,750 | — | — | $194.8K | 6 | 2015-05-21 |
| VIVUS INC (VVUS) Delisted | Director | 8,112 | — | — | $758.9K | 5 | 2013-05-30 |
| PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Director | 0 | — | — | -$20.28M | 31 | 2011-12-06 |
| CELGENE CORP /DE/ (CELG) Delisted | Director | 46,370 | — | — | $687.4K | 9 | 2010-06-18 |
| Alexza Pharmaceuticals Inc. (ALXA) Delisted | Director | 1,818 | — | — | $0 | 2 | 2007-07-26 |
Recent Filings · Page 22 of 31
301 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-08-08 | BSX | Buy (P) | +32,000 | $169.3K | EDGAR |
| 2012-06-19 | CELGENE CORP /DE/ (CELGZ) Delisted | Exer (M) | +685 | $0 | EDGAR |
| 2012-06-18 | XENOPORT INC (XNPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-06-15 | CELGENE CORP /DE/ (CELGZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-06-07 | — | Grant (A) | +10,000 | $0 | |
| 2012-05-10 | BSX | Grant (A) | — | $0 | EDGAR |
| 2012-04-30 | CELGENE CORP /DE/ (CELGZ) Delisted | Exer (M) | +16,958 | $785.2K | EDGAR |
| 2012-04-27 | VIVUS INC (VVUS) Delisted | Grant (A) | +20,000 | $0 | EDGAR |
| 2012-02-27 | BSX | Buy (P) | +10,000 | $59.1K | EDGAR |
| 2012-02-23 | BSX | Buy (P) | +10,000 | $59.3K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.